Researches we have conducted over the years classify various segments within the pharmaceutical industry on the basis of therapeutic area. We classify drugs solely on the basis of diseases they treat. Our researches on therapeutic area contain exhaustive information on various medications often administered as part of a surgical treatment. Market studies under this segment cover a plethora of therapeutic areas, i.e. from cardiovascular and gynecological to orthopedic and neurological, among others.

Drugs by Therapeutic Area
Pyrogen Testing Market (Test Type - Monocyte Activation Test (MAT), Limulus Amoebocyte Lysate (LAL) Test, Rabbit Pyrogen Test (RPT); Component - Instruments, Kits, Reagents; End user - Pharmaceutical Companies, Biotechnology Companies, Medical Device Companies) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026

Dec, 2018 | 250 pages

This report on pyrogen testing market studies the current as well as future prospects of the market globally. The stakeholders of this report include companies and intermediaries engaged in the manufacture, commercialization, providing pyrogen testing products as well as new entrants planning to enter this market. This report comprises an elaborate executive summary along with a market snapshot providing overall information of various segments and sub-segments considered in the scope of the study.

Drugs by Therapeutic Area
Hemophilia Treatment Drugs Market (Product Type - Recombinant Coagulation Factor Concentrates, Plasma derived Coagulation Factor Concentrates; Disease Indication - Hemophilia A, Hemophilia B, Others; Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026

Dec, 2018 | 188 pages

Hemophilia treatment drugs are products that are administered into the patient’s body in order to replace the blood clotting factors that are missing in their blood so that the blood can clot properly.  This report analyzes the current and future prospects of the hemophilia treatment drugs market based on product type, disease indication, distribution channel, and region.  

Drugs by Therapeutic Area
Drugs of Abuse Testing Market (Products - Analyzers, Rapid Testing Devices, Consumables; Sample Type - Saliva, Breath, Urine, Blood, Hair and Sweat; Testing Type - Pain Management Testing, Criminal Justice Testing, Workplace Screening; End user - Forensic Laboratories, Diagnostic labs, On-the-spot Testing, Forensic Laboratories) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026

Dec, 2018 | 196 pages

This report analyzes the current and future scenario of the global drugs of abuse testing market. Increase in impact of drug and alcohol abuse on public health, rise in demand for drug abuse testing among private employers, and surge in abuse of prescription drugs are projected to be major drivers of the global market during the forecast period.

Drugs by Therapeutic Area
Geriatric Medicines Market (Therapeutic Category - Analgesic, Antihypertensive, Statins, Antidiabetic, Proton Pump Inhibitor, Anticoagulant, Antipsychotic and Antidepressant; Condition - Cardiovascular, Arthritis, Diabetes, Neurological, Cancer, Osteoporosis, Respiratory; Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026

Nov, 2018 | 185 pages

This report on the global geriatric medicines market analyzes the current and future prospects of the market. The report comprises a comprehensive executive summary, including a market snapshot that provides overall information of various segments. The research is a combination of primary and secondary research. Primary research formed the bulk of our research efforts along with information collected from telephonic interviews and interactions via e-mails.

Drugs by Therapeutic Area
Botulinum Toxin Market (Product Type - Botulinum Toxin Type A and Botulinum Toxin Type B; Application - Aesthetic, Therapeutics) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018-2026

Nov, 2018 | 172 pages

This report analyzes the current and future scenario of the global botulinum toxin market. Botulinum toxin is a neurotoxin that is produced by the bacterium clostridium botulinum. There are around eight types of botulinum toxins A-H, produced by the bacterium. Botulinum toxin type A is capable of causing diseases in humans; however, it is widely utilized commercially and medically for the treatment of several aesthetic diseases such as glabellar lines, crow’s foot, and face and forehead wrinkles. Botulinum toxin is also utilized in the therapeutic treatment of spasticity, cervical dystonia, and migraine. Botulinum toxin procedure is a non-surgical cosmetic procedure that is noninvasive or minimally invasive in nature.

Drugs by Therapeutic Area
Viral Clearance Service Market (Application - Recombinant Proteins, Tissue and Blood Derived Products, Vaccines; Method - Viral Removal, Viral Inactivation (Chemical, Radiation); End user - Biopharmaceuticals, Contract Research Organizations, Academic Research Institutes) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026

Nov, 2018 | 208 pages

This report on the global viral clearance service market comprises an elaborate executive summary, including a market snapshot that provides information about various segments of the market. The report also provides information and data analysis of the global market with respect to its segments based on application, method, end-user, and region. A detailed qualitative analysis of drivers, restraints, and opportunities of the market has been provided in the market overview section.

Drugs by Therapeutic Area
T-cell Acute Lymphoblastic Leukemia Market (Treatment - Chemotherapy, Radiation Therapy, Bone Marrow Transplant, Targeted Therapy, Immunotherapy; End user - Hospital, Clinics, Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026

Nov, 2018 | 170 pages

This report analyzes the current and future scenario of the global T-cell acute lymphoblastic leukemia market. Increase in patient population with T-cell acute lymphoblastic leukemia, growth of the pharmaceutical industry, improvement in health care infrastructure, and increase in the number of clinical trials are projected to be major drivers of the global market during the forecast period.

Drugs by Therapeutic Area
Pharmacy Repackaging Systems Market (Product Type - Blister Card/Compliance Packaging Systems, Pouch Packaging Automation Systems, Bottle Filling/ Pill Counting Automation Systems, Liquid Medication Packaging Systems; End user - Retail/Community Pharmacy, Hospital Pharmacy, Long-term Care (LTC) Pharmacies, Mail Order Pharmacies) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026

Nov, 2018 | 200 pages

This report on the global pharmacy repackaging systems market analyzes the current and future prospects of the market. The report comprises an elaborate executive summary, including a market snapshot that provides overall information of various segments and sub-segments. The research is a combination of primary and secondary research. Primary research formed the bulk of our research efforts along with information collected from telephonic interviews and interactions via e-mails. 

Drugs by Therapeutic Area
Prescription Dermatology Therapeutics Market (Product Type - Acne and Rosacea Drugs, Psoriasis Drugs, Dermatitis and Seborrhea Drugs, Fungal Infection Drugs, Skin Cancer; Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Mail Order Pharmacies) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026

Nov, 2018 | 183 pages

The global prescription dermatology therapeutics market has been studied for the forecast period from 2018 to 2026. For research, 2017 has been considered as the base year and 2016 as the historical year.

Drugs by Therapeutic Area
Sterilization Equipment and Disinfectant Market (Method - Heat Sterilization, Filtration Sterilization, Low Temperature Sterilization, Radiation Sterilization; Disinfectant - Oxidizing Agents, Non oxidizing Agents; End user - Hospitals and Diagnostic Centers, Medical Devices Companies, Pharmaceutical Companies, Research and Educational Institutes) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026

Nov, 2018 | 213 pages

Sterilization is a vital component for infection-control. Medical devices require sterilization and disinfection after their usage, since they get contaminated. The global sterilization equipment and disinfectant market is expanding at a significant pace due to factors such as rise in number of surgeries and increase in number of hospital acquired associated infection.

Drugs by Therapeutic Area
Drug Eluting Balloon Market (Product - Coronary Drug Eluting Balloon, Peripheral Drug Eluting Balloon; Drug Coating Technology - Paccocath, FreePac, TransPax, EnduraCoat) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026

Oct, 2018 | 212 pages

This report studies the current as well as future prospects of the global drug eluting balloon market. Stakeholders of this report include companies and intermediaries engaged in the manufacturing, commercialization, and provision of e eluting balloons and new players planning to enter the market. The report comprises an elaborate executive summary, along with a market snapshot, providing overall information on various segments considered in the scope of the study.

Drugs by Therapeutic Area
Pneumococcal Vaccines Market (Product - Synflorix, Prevenar-13, PCV 13, V114, PCV-20, PCV-10, PPSV-23; Distribution Channel - Wholesalers (pharmacy channel), Specialized Companies, Public Authorities; Sector - Public, Private) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026

Oct, 2018 | 285 pages

This report analyzes the current and future scenario of the global pneumococcal vaccines market. Increase in patient population, growth of the pharmaceutical industry, rise in government investments for vaccination programs, improvement in health care infrastructure, and surge in the number of clinical trials are projected to be the major drivers of the global market during the forecast period.

Drugs by Therapeutic Area
Pediatric Neuroblastoma Treatment Market (Therapy Type - Immunotherapy, Chemotherapy; Distribution Channel - Hospital Pharmacies, Retail Pharmacies amd Drug Stores) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026

Oct, 2018 | 143 pages

This report by Transparency Market Research analyzes the global pediatric neuroblastoma treatment market for the period between 2018 and 2026. An in-depth market assessment has been made, which offers readers accurate analysis. Market projections have been offered in terms of value (US$ Mn). Stakeholders of this report include companies and intermediaries engaged in the manufacture and commercialization of various products as well as new players planning to enter this market.

Drugs by Therapeutic Area
Intravenous Immunoglobulin Market (Indication - Chronic Inflammatory Demyelinating Polyneuropathy, Primary Humoral Immunodeficiency, Idiopathic Thrombocytopenic Purpura, Guillain-Barre Syndrome, Myasthenia Gravis, Multifocal Motor Neuropathy, Kawasaki Disease, Hypogammaglobulinemia, Chronic Lymphocytic Leukemia; End user - Hospitals, Clinics, Home Care) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026

Oct, 2018 | 232 pages

This report analyzes the current and future prospects of the global intravenous immunoglobulin market. It comprises an elaborate executive summary, including a market snapshot that provides overall information of various segments. The report is a combination of primary and secondary research. Primary research formed the bulk of the research efforts along with information collected from telephonic interviews and interactions via e-mails.

Drugs by Therapeutic Area
Tyrosine Kinase Inhibitors Market (Product - BCR-ABL Tyrosine Kinase Inhibitor, Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors, Vascular Endothelial Growth Factor (VEGFR) Tyrosine Kinase Inhibitors, Other Tyrosine Kinase Inhibitors; Application - Chronic Myeloid Leukemia (CML), Lung Cancer, Breast Cancer, Renal Cell Cancer; Distribution Channel - Hospital Pharmacies, Independent Pharmacies, Online Pharmacies) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026

Oct, 2018 | 250 pages

This report on the tyrosine kinase inhibitors market analyzes the current and future scenario of the global market. Increasing expenditure on health care, high prevalence and rise in incidence of cancer, and rise in demand for tyrosine kinase inhibitors for lungs cancer & breast cancer treatment are boosting the usage of tyrosine kinase inhibitors. Health benefits of tyrosine kinase inhibitors and focus of companies on expanding indications of existing and pipeline TKIs are major drivers of the global tyrosine kinase inhibitors market.

Drugs by Therapeutic Area
Veterinary Vaccines Market (Technology - Inactivated Vaccines, Conjugate Vaccines, Live Attenuated Vaccines, Toxoid Vaccines; Animal Type - Livestock Animal Vaccines, Companion Animal Vaccines) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026

Sep, 2018 | 213 pages

Vaccines are products designed to trigger immune response to fight future infection. Vaccination can prevent many pet illness and avoid costly treatments of diseases that can be prevented. The global veterinary vaccines market is expanding at a significant pace due to factors such as new technological advances in vaccines development, continuous development of drug resistance by pathogens, and emergence of new diseases.

Drugs by Therapeutic Area
Hospital Infection Therapeutics Market (Therapeutics - Anti-bacterial Drugs, Anti-fungal Drugs, Anti-viral Drugs; Infection - Hospital Acquired Pneumonia, Urinary Tract Infections, Gastrointestinal Disorders, Bloodstream Infections, Surgical Site Infections, Other Hospital Infections) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026

Sep, 2018 | 208 pages

This report studies the current as well as future prospects of the global hospital infection therapeutics market. Stakeholders of this report include companies and intermediaries engaged in the manufacture, commercialization, and provision of hospital infection therapeutics and new players planning to enter the market. This report comprises an elaborate executive summary along with a market snapshot providing overall information of various segments considered in the scope of the study

Drugs by Therapeutic Area
Glaucoma Therapeutics Market (Drug Class - Prostaglandins, Beta Blockers, Alpha Agonists, Carbonic Anhydrase Inhibitors, Combination Medications, Cholinergics; End use - Hospitals, Ophthalmic Clinics, Ambulatory Surgical Centers) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026

Aug, 2018 | 185 pages

This report analyzes the current and future prospects of the global glaucoma therapeutics market. The report comprises a comprehensive executive summary, including a market snapshot that provides overall information of various segments. The research is a combination of primary and secondary research.

Drugs by Therapeutic Area
Transplant Diagnostic Market (Screening - Pre-Transplant Diagnostic, Post-Transplant Diagnostic; Technique - Molecular Assay, Non-Molecular Assay; Application - Stem Cell Transplantation, Solid Organ Transplantation (Kidney, Liver, Heart, Lungs, Pancreas, Small Bowel); Product and Services - Reagents and Consumables, Instruments, Software; End user - Hospital and Transplant Centers, Research Laboratories) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018 - 2026

Aug, 2018 | 295 pages

This report on the transplant diagnostic market analyzes the current and future scenario of the global market. Rising incidence of chronic diseases such as chronic kidney disease (CKD), end-stage renal disease, coronary artery disease, and acute & chronic hepatitis among all age groups, particularly the geriatric population, is increasing the usage of transplant diagnostic techniques owing to the rise in organ transplantation.

Drugs by Therapeutic Area
Blood Group Typing Market (Product - Instrument (Automated, Semi-automated, Manual), Consumables (Reagent, Test Kits, Antisera), Services; Technique - PCR-based, Microarray-based, Assay-based Technique, Massively Parallel Technique; Test - Antibody Screening, HLA Typing, ABO Blood Test, Cross Matching Test, Antigen Typing; End use - Hospitals, Clinical Laboratories, Blood Bank - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026

Aug, 2018 | 234 pages

This report studies the current as well as future prospects of the global blood group typing market. Stakeholders of this report include companies and intermediaries engaged in the manufacture, commercialization, and provision of products for blood group typing and new players planning to enter the market. This report comprises an elaborate executive summary along with a market snapshot providing overall information of various segments and sub-segments considered in the scope of the study.

Drugs by Therapeutic Area
Animal Parasiticides Market (Product - Ectoparasiticides (Oral Tablets, Dips, Spray, Spot-on), Endoparasiticides (Oral Suspension, Injectable, Feed Additives), Endectocides; Species - Food Producing Animals (Cattle, Poultry, Swine), Companion Animal (Dogs, Felines), Other Livestock) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026

Aug, 2018 | 281 pages

This report on the animal parasiticides market analyzes the current and future scenario of the global market. Increase in disease indication among livestock, technological advancement of application of parasiticides methodology, and adoption of companion animals is anticipated to boost the animal parasiticides market. Increase trading facilities of live hogs/pigs, demand for meat, and innovation through clinical research activities are key drivers that are expected to drive the global animal parasiticides market during the forecast period.

Drugs by Therapeutic Area
Scar Treatment Market (Treatment Type - Topical Products (Creams, Gels, Silicone Sheets, Others (Sprays, Oils, etc.), Laser Treatment (CO2 Lasers, Pulsed Dye Laser, and Excimer Laser), Injectables; Scar Type - Atrophic & Acne Scars, Hypertrophic Scars and Keloids, Contracture Scars, and Others (Stretch Marks); Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026

Jul, 2018 | 209 pages

This report studies the current as well as future prospects of the global scar treatment market. Stakeholders of this report include companies and intermediaries engaged in the manufacture, commercialization, and provision of scar treatment for skin problems, and new players planning to enter the market.

Drugs by Therapeutic Area
Pigmentation Disorders Treatment Market (Treatment - Topical Drugs, Laser Therapy, Chemical Peels, Phototherapy, Microdermabrasion; Key Disease Indications - Hyperpigmentation (Melasma, Post-inflammatory Hyperpigmentation, Solar Lentigines), Hypopigmentation (Vitiligo, Albinism); End use - Hospitals, Aesthetic Clinics and Dermatology Centers) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026

Jul, 2018 | 248 pages

This report analyzes the global pigmentation disorders treatment market in terms of its current and future scenario. Rise in investment in R&D of novel advanced technologies, decrease in social taboos regarding pigmentation, increase in prevalence of pigmentation-related disorders, and rise in awareness about skin rejuvenation and treatment options are likely to drive the expansion of the global market during the forecast period. Pigmentation therapies can be classified as topical drugs, microdermabrasion, chemical peels, phototherapy, and laser therapy. These therapies are available in hospitals and aesthetic clinics & dermatology centers.

Drugs by Therapeutic Area
Hyperpigmentation Disorders Treatment Market (Treatment Type - Topical Drugs, Laser Therapy, Chemical Peels, Phototherapy, Microdermabrasion; Disease Indication - Melasma, Post-inflammatory Hyperpigmentation, Solar Lentigines; End use - Hospitals, Aesthetic Clinics & Dermatology Centers) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026

Jul, 2018 | 201 pages

This report analyzes the global hyperpigmentation disorders treatment market in terms of its current and future scenario. Rise in investment in R&D of novel advanced technologies, decrease in social taboos regarding pigmentation, increase in prevalence of hyperpigmentation-related disorders, and rise in awareness about skin rejuvenation and treatment options are likely to drive the growth of the global market during the forecast period. Anti-pigmentation therapies can be classified as topical drugs, microdermabrasion, chemical peels, and laser therapy. These therapies are available in hospitals and aesthetic clinics & dermatology centers.

Drugs by Therapeutic Area
Thrombosis Drugs Market (Drug Class - Factor Xa Inhibitor, Low Molecular Weight Heparin, P2Y12 Platelet Inhibitor; Indication - Pulmonary Embolism, Atrial Fibrillation, Deep Vein Thrombosis; Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026

Jul, 2018 | 252 pages

Thrombosis drugs help in the prevention or inhibition of thrombus, by mimicking the role of antithrombin, a protein molecule produced in the body, which helps clotting of the blood. Antithrombin is a small protein involved in the inactivation of several enzymes in the coagulation system. The global thrombosis drugs market is expanding at a significant pace due to factors such as increase in the cases of cancer and the number of patients consuming high amounts of tobacco, worldwide.

Drugs by Therapeutic Area
Post-operative Nausea and Vomiting (PONV) Market (Treatment Type - Serotonin Antagonists, Steroids, Dopamine Antagonists, NK-1 Receptor Antagonists, Non-pharmacological Treatment; Distribution Channel - Hospital Pharmacies, Online Pharmacies, Retail Pharmacies & Drug Stores) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026

Jul, 2018 | 166 pages

The report comprises an elaborate executive summary along with a market snapshot providing overall information of various segments considered in the scope of the study. The section also provides overall information and data analysis of the global post-operative nausea and vomiting (PONV) market with respect to the leading market segments based on treatment type, distribution channel, and region.

Drugs by Therapeutic Area
Antiseptic and Disinfectant Market (Product - Quaternary Ammonium Compounds, Chlorine Compounds, Alcohols, Aldehydes, Phenolic Compounds, Hydrogen Peroxide, Iodine, Silver; End use - Healthcare Providers, Commercial Users, Domestic Users) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026

Jun, 2018 | 210 pages

This report on the antiseptic and disinfectant market analyzes the current and future scenario of the global market. Large number of hospital acquired infections and wound care therapy among the geriatric population after surgery is increasing the usage of antiseptic and disinfectant. Less pain and high definition in eliminating infectious organisms are major drivers of the global antiseptic and disinfectant market.

Drugs by Therapeutic Area
Erectile Dysfunction (ED) Drugs Market (Drug - Viagra, Cialis, Staxyn/Levitra, Stendra/Spedra; Distribution Channel - Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) - Global Industry Analysis, Pipeline Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026

Jun, 2018 | 196 pages

This report studies the current as well as future prospects of the global erectile dysfunction (ED) drugs market. Stakeholders of the market include companies and intermediaries engaged in the manufacture, commercialization, and marketing of therapeutic drugs for the treatment of erectile dysfunction, as well as new players planning to enter the market.

Drugs by Therapeutic Area
Pediatric Health Care Products and Services Market (Drug Class - Antibiotics, Analgesics, Anti-asthmatics, Antidepressants, Antidiarrheal, Antifungal, Anti-histamines, Antihypertensives, Anti-metabolites, Anti-neoplastic Antibiotics, Antipsychotics; Disease/Disorder - Allergy and Respiratory, Cancer, Cardiovascular, Central Nervous System, Gastrointestinal, Hormonal Imbalance, Infections; Service Type - Child Psychiatry Services, Gastrointestinal Services, Pediatric Cancer Services, Pediatric Diabetes Services, Pediatric Heart Services) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026

Jun, 2018 | 271 pages

This report on the pediatric health care products and services market analyzes the current and future scenario of the global market. Expansion of the pediatric health care products and services market is attributed to unhealthy lifestyle habits; rise in obese pediatric population; increase in funding for pediatric research, which contributes to new product launches; growth in awareness regarding pediatric care; economic growth in emerging markets; and technical advancement in the sector. 

Drugs by Therapeutic Area
Toxicology Testing Services Market (Method - In Vivo Method, In Vitro Method, In Silico Method; Type of Industry - Pharmaceutical & Biotechnology, Cosmetic, Chemical, Medical Devices, and Others - Food, Agricultural, Environmental) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026

May, 2018 | 201 pages

This comprehensive report by Transparency Market Research analyzes the global toxicology testing services market for the period between 2018 and 2026. An in-depth and unbiased market assessment has been made, which offers readers an in-depth and accurate analysis. Market projections have been offered in terms of value (US$ Mn). Stakeholders of this report include companies and intermediaries engaged in research & development of new drug molecules, new chemicals, manufacturers of chemicals listed under REACH regulations, and toxicology testing services providing contract research organizations.

Drugs by Therapeutic Area
Thalassemia Treatment Market (Treatment Type - Blood Transfusion, Chelating Therapy, Bone Marrow Transplant, and Others (surgery, general medicines)) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026

May, 2018 | 193 pages

This report analyzes the current and future scenario of the global thalassemia treatment market. Large number of health care investors such as governments, social security funds, and insurance companies are struggling to meet the rising costs of medical treatments and research & development. Promising pipeline drugs and novel therapies, programs for increasing awareness about thalassemia, and rise in prevalence of thalassemia are the major drivers of the global thalassemia treatment market.

Drugs by Therapeutic Area
Motion Sickness Treatment Market (Treatment Type - Anticholinergic, Antihistamines; Route of Administration - Oral, Transdermal; Distribution Channel - Retail Pharmacies, Online Pharmacies) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026

May, 2018 | 166 pages

Motion sickness is a common condition characterized by a set of symptoms such as dizziness, nausea, and fatigue experienced by a person while traveling. It is caused by difference in impulses received by perceived sense of motion by visual senses and vestibular system’s sense of movement. Conflict among those senses result in motion sickness. Motion sickness is estimated to be experienced by around 50% travelers; it is most widely witnessed among children and elderly people. Various prescription and OTC drugs and products are used to treat motion sickness and provide relief from its symptoms. Anticholinergic, antihistamines, and sympathomimetic are the most commonly used medications, while traditional remedies such as herbal medicines, homeopathic medicines, and others are also available as OTC products for treatment of motion sickness.

Drugs by Therapeutic Area
Depression Drugs Market ( Drug Class - Atypical Antipsychotics, Serotonin-Norepinephrine Reuptake Inhibitor, Selective Serotonin Reuptake Inhibitor, Central Nervous System (CNS) Stimulant; Disease Type - Major Depressive Disorder, Schizophrenia and Bipolar I Disorder, Selective Serotonin Reuptake Inhibitor Induced; Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Pharmacies - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026

May, 2018 | 288 pages

This report analyzes the global depression drugs market in terms of its current and future scenario. Increase in prevalence of major depression disorders, rise in government initiatives in creating awareness about depression drugs, and growth in geriatric population across the world are expected to drive the depression drugs market during the forecast period.

Drugs by Therapeutic Area
Periodontal Therapeutics Market (Product Type - Systemic Antibiotics (Doxycycline, Minocycline, Metronidazole), Local Antibiotics (Arestin, Atridox, PerioChip); Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Drug Stores, E-commerce - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026

May, 2018 | 179 pages

Periodontal therapeutics are effective adjunctive therapies used in the treatment of periodontal pathogens. These therapies include systemic antibiotics, such as doxycycline, minocycline, metronidazole, and other antibiotics comprising amoxicillin, azithromycin, etc. and local antibiotics, including Arestin, Atridox, PerioChip, and others. This report analyzes the current and future prospects of the periodontal therapeutics market based on product type, distribution channel, and geography.

Drugs by Therapeutic Area
Plasma Protein Therapeutics Market (Product - Coagulation Factors, Immunoglobulins, Albumins, C1-esterase Inhibitors, and Alpha-1 Proteinase Inhibitors and Hyperimmune Globulins; Application - Hemophilia, Primary Immunodeficiency Disorder, Idiopathic Thrombocytopenic Purpura, Secondary Immunodeficiency (CLL, Multiple Myeloma, and Congenital AIDS), and Hereditary Angioedema, Kawasaki Disease, GBS, and CIDP) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2024

May, 2018 | 144 pages

Transparency Market Research’s new report on the global plasma protein therapeutics market presents detailed insights into growth of the market for the 2017-2024 forecast timeframe. The growth analysis of this market for the aforementioned forecast period is presented based on past and current growth scenario. The report comprises a detailed executive summary, wherein a market snapshot provides information on various segments and sub-segments.

Drugs by Therapeutic Area
Allergy Immunotherapy Market (Treatment Type - Subcutaneous Immunotherapy (SCIT), Sublingual Immunotherapy (SLIT); Allergy Type - Allergic Rhinitis, Asthma, Food Allergy, Venom Allergy; Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Drug Stores, Online Pharmacies) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025

Apr, 2018 | 191 pages

This report studies the current as well as future prospects of the global allergy immunotherapy market. Stakeholders of the market include companies and intermediaries engaged in the manufacture, commercialization, and provision of immunotherapeutic drugs for treatment of allergy, as well as new players planning to enter the market.

Drugs by Therapeutic Area
Regulatory Affairs Outsourcing Market (Services - Regulatory Submissions, Clinical Trial Applications and Product Registrations, Regulatory Writing and Publishing, and Consulting and Legal Representation) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 - 2023

Apr, 2018 | 76 pages

This research study analyzes the market for regulatory affairs outsourcing services in terms of revenue (US$ Mn). The stakeholders of this report comprises the clinical research organizations. The global regulatory affairs outsourcing market has been broadly segmented on the basis of services (Regulatory Submissions, Clinical Trial Applications and Product Registrations, Regulatory Writing and Publishing, Regulatory Consulting and Legal Representation and others regulatory affairs, and Geography (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa). 

Drugs by Therapeutic Area
Guillain-Barré Syndrome Market (Therapeutics - Intravenous Immunoglobulin, Plasma Exchange, Others (Analgesics, Anticonvulsants, LMWH); Route of Administration - Oral, Parenteral; Distribution Channel - Hospital Pharmacies, Retail Pharmacies, and Others (Home Care, Clinics)) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025

Apr, 2018 | 194 pages

This report on the global Guillain–Barré syndrome market studies the current as well as future prospects of the market globally. Stakeholders of this report include companies and intermediaries engaged in the manufacture and commercialization of products for the treatment of Guillain–Barré syndrome as well as new entrants planning to enter the market. 

Drugs by Therapeutic Area
Scleroderma Diagnostics and Therapeutics Market (Drug Class - Corticosteroids, Immunosuppressive Agents, Endothelin Receptor Agonists, Calcium Channel Blockers, PDE-5 Inhibitors, Chelating Agents, Prostacyclin Analogues, H2 Blockers, Proton Pump Inhibitors, and ACE Inhibitors; Indication - Localized and Systemic; Diagnostic Test Type - Skin Biopsy, Imaging Techniques, Blood Test, Electrocardiogram and Echocardiogram, and Pulmonary Function Tests) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2024

Apr, 2018 | 176 pages

The scleroderma diagnostics and therapeutics market report studies the scleroderma diagnostics and therapeutics market globally as well as regionally for the forecast period from 2017 to 2024. The report provides valuable insights into the growth of the said market, wherein revenue estimates are presented in US$ Mn and volume estimates in Kilo tons.

Drugs by Therapeutic Area
Oral Thin Films Market (Product - Sublingual Film, Fast Dissolving Dental/Buccal Film; Disease Indication - Schizophrenia, Migraine, Opioid Dependence, Nausea and Vomiting; Distribution Channel - Hospital Pharmacies, Drug Stores, Retail Pharmacies, E-commerce) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026

Apr, 2018 | 201 pages

This report analyzes the current and future scenario of the global oral thin films market. Rise in demand for thin film drug delivery systems, considerable research and development in the segment, low development cost as compared to new drugs, and strategic alliances between novel technology owners and pharmaceutical giants are the major drivers of the global oral thin films market.

Drugs by Therapeutic Area
Parkinson’s Disease Therapeutics Market (Drug Class - Levodopa Combination, Dopamine Agonists, MAO-B Inhibitors, COMT Inhibitors; Route of Administration - Oral, Transdermal, Subcutaneous, Intestinal Infusion; Distribution Channel - Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025

Apr, 2018 | 211 pages

This report on Parkinson’s disease therapeutics market studies the current as well as future prospects of the market globally. Stakeholders of the market include companies and intermediaries engaged in the manufacturing, commercialization, providing therapeutic drugs for treatment of Parkinson’s disease, as well as new entrants planning to enter the market.

Drugs by Therapeutic Area
Generic Injectables Market (Product Type - Large Molecule Injectables (Biosimilars), Small Molecule Injectables; Container Type - Vials, Ampoules, Premixes, Prefilled Syringes; Injectables Market - Oncology, Infectious Diseases, Cardiology, Diabetes, Immunology; Route of Administration - Intravenous, Intramuscular, Subcutaneous) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025

Apr, 2018 | 203 pages

This comprehensive report by Transparency Market Research analyzes the global generic injectables market for the period between 2017 and 2025. An in-depth and unbiased market assessment has been made, which offers an in-depth and accurate analysis. Market projections have been offered in terms of value (US$ Mn). Stakeholders of this report include companies and intermediaries engaged in manufacturing and distribution of generic injectable products as well as new entrants planning to enter this market.

Drugs by Therapeutic Area
Respiratory Syncytial Virus (RSV) Therapeutics Market (Drugs Type - Palivizumab, Ribavirin; Dosage Form - Oral, Injectable; Distribution Channel - Drug stores and Retail Pharmacies, Hospital Pharmacies, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025

Apr, 2018 | 176 pages

Respiratory syncytial virus infection is highly contagious. It is reported to be the most common cause of pneumonia and bronchiolitis in children as well as adults. According to the Center for Disease and Prevention, around 25-40 of every 100 children exposed to RSV infection for the first time develop signs of bronchiolitis or pneumonia. No approved drugs have been available in the market to treat RSV infection till date, and only prophylaxis drugs have been used. Therefore, several biopharmaceutical companies are investing in research and development in order to develop new drugs and vaccine to treat or prevent the RSV infection.

Drugs by Therapeutic Area
Porcine Vaccines Market (Disease Indication - Diarrhea, Swine Influenza, Arthritis, Bordetella Rhinitis, Porcine Reproductive and Respiratory Syndrome (PRRS), Porcine Circovirus Associated Disease (PCVAD); End use - Veterinary Hospitals and Hog Production Farms; Technology - Inactivated Vaccines, Live Attenuated Vaccines, Toxoid Vaccines, Recombinant Vaccines, Conjugate Vaccines, DNA Vaccines): Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025

Apr, 2018 | 240 pages

This report on the porcine vaccines market analyzes the current and future scenario of the global market. Increase in the prevalence of diseases among swine, technological advancements of RNA strand methodology, and cultivation of pigs to raise standards of living are likely to drive the global porcine vaccines market during the forecast period. Increase in the number of trading facilities for live hogs/pigs, rise in the demand for pork meat, and innovations through clinical research activities are some of the factors expected to drive the global porcine vaccines market during the forecast period.

Drugs by Therapeutic Area
Collagen Peptide and Gelatin Market (Type - Type I (Fish and Others), and Type II (Hydrolyzed and Undenatured)) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025

Mar, 2018 | 100 pages

This report provides in-depth region wise and country wise analysis of the collagen peptide and gelatin market. Stakeholders of this report include manufacturers of collagen peptide products, raw material suppliers, nutraceutical and cosmeceutical companies, food processing industries and new players planning to enter the market.

Drugs by Therapeutic Area
Anti-infective Drugs Market (Type - Anti-bacterial Drugs (B-lactams, Quinolones, Macrolides, Tetracycline, Aminoglycoside, Others (Sulfonamide, Phenicols)), Anti-fungal Drugs (Azoles, Echinocandins, Polyenes), Anti-viral Drugs; Indication - Pneumonia, Methicillin-resistant Staphylococcus Aureus (MRSA), Sepsis, Tuberculosis, Dermatophytosis, Aspergillosis, Candidiasis, Hepatitis Virus Infection, HIV Infection, Respiratory Virus Infection; Distribution Channel - Hospital Pharmacy, Retail Pharmacy, Online Sales) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017-2025

Mar, 2018 | 235 pages

This report studies the current as well as future prospects of the global anti-infective drugs market. Stakeholders of this report include companies and intermediaries engaged in the manufacture, commercialization, and provision of anti-infective drugs for pneumothorax and pleural effusion treatment as well as new players planning to enter this market. This report comprises an elaborate executive summary along with a market snapshot providing overall information of various segments and sub-segments considered in the scope of the study. This section also provides overall information and data analysis of the global anti-infective drugs market with respect to the leading market segments based on type, indication, distribution channel, and region.

Drugs by Therapeutic Area
Pulmonary Drug Delivery Devices Market (Product Type - Dry Powder Inhalers, Metered Dose Inhalers and Nebulizers; Application - Asthma, COPD, and Cystic Fibrosis; Distribution Channel - Retail Pharmacies, Hospital Pharmacies, and E-commerce) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2019

Mar, 2018 | 93 pages

This report on pulmonary drug delivery devices studies the current as well as future prospects of the market globally. The stakeholders of this report include companies and intermediaries engaged in the manufacture and commercialization of various pulmonary/respiratory drugs and/or drug-device combinations as well as new entrants planning to enter this market.

Drugs by Therapeutic Area
Human Papillomavirus Vaccine Market (Valence - Bivalent, Quadrivalent, Nonavalent; Indication - Cervical Cancer, Anal Cancer, Vaginal Cancer, Penile Cancer, Vulvar Cancer, Oropharyngeal Cancer, Genital Warts; Distribution Channel - Physicians, Wholesalers, Physician Distributors, Government Entities, Public and Private Alliances) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025

Mar, 2018 | 212 pages

This report on the global human papillomavirus vaccine market analyzes the current and future scenario of the global market. Rise in private and public funding for human papillomavirus vaccine, increase in government initiatives to prevent cervical cancer caused by human papillomavirus, growth in prevalence of various cancers caused by human papillomavirus are expected to drive the market during the forecast period.

Drugs by Therapeutic Area
Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Market (Drug Class - Lipopeptide, Oxazolidinone, Cephalosporin, Tetracycline, Lipoglycopeptide, Folate Antagonist; Route of Administration - Oral and Parenteral; Distribution Channel - Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025

Mar, 2018 | 177 pages

This report on the Global Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Market analyzes the current and future scenario of the global market. Rise in private and public funding for R&D of novel anti-MRSA drug molecules, increase in prevalence of MRSA infections, and their improved screening are boosting the growth of the global MRSA drugs market.

Drugs by Therapeutic Area
Neuroprotection Market (Product - Free Radical Trapping Agents (Antioxidants), Glutamate Antagonists (Anti-Excitotoxic Agents), Apoptosis Inhibitors, Anti-inflammatory Agents, Neurotrophic Factors (NTFs), Metal Ion Chelators, Stimulants; Application - Prevention, Treatment) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025

Mar, 2018 | 197 pages

This report on the Neuroprotection market analyzes the current and future scenario of the global market. Increasing incidence of neurological disorders. Product development, drug launches and initiatives for increasing awareness about Neuroprotection are the major drivers of the global Neuroprotection Market.

Drugs by Therapeutic Area
Cardiovascular Drugs Market (Drug Class - Anti hyperlipidemics, Anti-hypertensives, Anti-coagulants, Anti-fibrinolytics, Anti-arrhythmic; Distribution Channels - Hospital Pharmacies, Online Pharmacies, Retail Pharmacies) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025

Mar, 2018 | 241 pages

Cardiovascular drugs are widely used for treating various heart related dysfunction. With increasing number of cardiovascular diseases across the globe is the major driving factor for the growth of the cardiovascular diseases. According to the study conducted by Global Burden of Diseases estimate that the death rate due to CVD is 235 per 100000 in global population. According to WHO, cardiovascular diseases account for 31% deaths globally which is approximately 17.7 million individuals.

Drugs by Therapeutic Area
Bone Marrow Aspirate Concentrates Market (Product Type - Bone Marrow Aspirate Concentrates Systems, Bone Marrow Aspirate Concentrates Accessories; Application - Orthopaedic Surgery, Wound Healing, Chronic Pain, Peripheral Vascular Disease, Dermatology; Industry - Hospitals and Clinics, Pharmaceutical and Biotechnology Companies, Contract Research Organizations (CROs), Contract Manufacturing Organizations (CMOs), Academic & Research Institutes) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025

Mar, 2018 | 180 pages

This report on the bone marrow aspirate concentrates market analyzes the current and future scenario of the global market. Growth of the global bone marrow aspirate concentrates market is driven by increased prevalence of and incidences of orthopedic diseases, and sports injuries, along with high growth of the cosmetic surgery industry and increasing applications of the BMAC products in the cosmetic and orthopedic surgeries. However, pain associated with the treatment, lack of product approval, and preference for alternative treatments are factors hampering the market growth.

Drugs by Therapeutic Area
Glaucoma Treatment Market (Product Type - Prostaglandin Analogs (PGAs), Alpha Agonist, Beta Blockers, Cholinergic, Carbonic Anhydrase Inhibitors, and Combined Medications; Indication - Angle Closure Glaucoma (ACG), Open Angle Glaucoma (OAG), Secondary Glaucoma, Congenital Glaucoma, and Other Indications; Sales Channel - Hospital Pharmacies, Retail Pharmacies, and Online Sales) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 - 2026

Feb, 2018 | 170 pages

World Health Organization (WHO) has stated glaucoma to be the second largest cause of blindness across the globe, trailing cataract. Among the types, closed angle glaucoma (CAG) and open angle glaucoma (OAG) account for over half cases of glaucoma worldwide. With the surge in geriatric population across the globe, which has a relatively higher risk of developing the disease, demand for glaucoma treatment is likely to witness a surge.

Drugs by Therapeutic Area
Cancer Cachexia Market (Therapeutics - Progestogens and Corticosteroids Combination Therapies; Mechanism of Action - Appetite Stimulators and Weight Loss Stabilizers; Distribution channels - Hospital Stores, Retail Pharmacy Stores, and Online Pharmacy) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025

Feb, 2018 | 218 pages

This report on the cancer cachexia market analyzes the current and future scenario of the global market. Growth of the global cancer cachexia market is driven by high investments made in cutting-edge drug research resulting in new, sophisticated treatments with specific mechanism of action. Moreover, rising emphasis on palliative cancer care will further boost the market in near future. The cancer cachexia market report comprises an elaborate executive summary, which includes a market snapshot that provides information about various segments of the market.

Drugs by Therapeutic Area
Thyroid Gland Disorders Treatment Market (Disorders - Hypothyroidism (Levothyroxine and Liothyronine) and Hyperthyroidism (Imidazole and Propacil)) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2017 - 2025

Feb, 2018 | 173 pages

This report on the thyroid gland disorders treatment market analyzes the current and future scenario of the global market. Increasing incidence of thyroid gland disorders. Government regulations and initiatives for increasing awareness about thyroid gland disorders treatment are the major drivers of the global Thyroid Gland Disorders Treatment Market.

Drugs by Therapeutic Area
Unfractionated Heparin Market (Source -Bovine and Porcine; Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies) - Global Industry Analysis, Size, Share, Growth, Trends, & Forecast 2017- 2025

Feb, 2018 | 142 pages

This report on unfractionated heparin market studies the current as well as future prospects of the market globally. The stakeholders of this report include companies and intermediaries engaged in the manufacture, commercialization, providing unfractionated heparin products as well as new entrants planning to enter this market. This report comprises an elaborate executive summary along with a market snapshot providing overall information of various segments and sub-segments considered in the scope of the study.

Drugs by Therapeutic Area
Insomnia Market (Treatment Type - Benzodiazepines, Nonbenzodiazepines, Antidepressants, Orexin Antagonist, Melatonin Antagonist, Devices, and Other Treatment Types; Sales Channel - Hospital Pharmacies, Retail Pharmacies and Drug Stores, and Online Pharmacies) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2026 Featured

Jan, 2018 | 170 pages

According to the Sleep Health Foundation, Insomnia has been estimated to affect over one-third of the global population. Insomnia is characterized on the basis of multiple patterns such as difficulty in sleep initiation & maintenance that is usually accompanied with awakening too early & trouble sleeping again or frequent awakenings. Long-term insomnia has impacted daily life of individuals suffering from the disease, and has been associated with nervous breakdown or severe depression if left untreated. 

Drugs by Therapeutic Area
Inflammatory Bowel Disease (IBD) Treatment Market (Drug Class - TNF Inhibitors, Aminosalicyclates, Immunomodulators, and Corticosteroids; Disease Indication - Ulcerative Colitis and Crohn’s Disease; Distribution Channel - Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025

Jan, 2018 | 207 pages

Inflammatory bowel disease is a group of medical indication that causes chronic inflammation in the gastrointestinal tract. The inflammatory bowel disease mainly comprises of Ulcerative colitis and Crohn’s disease. The ulcerative colitis primarily affects the large intestine and anus and it causes the inflammation sores in the inner lining of colon and rectum.

Drugs by Therapeutic Area
Topical Pain Management Therapeutics in Sports Medicine Market (Product - Gels, Cream, Sprays, and Patches (Drug in Adhesive, Matrix, and Reservoirs); Therapeutic Class - Analgesics (Opioids, Non-opioids), Anesthetics, and Skeletal Muscle Relaxants) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025

Jan, 2018 | 200 pages

This report on the global topical pain management therapeutics in sports medicine market analyzes the current and future prospects of the market. The report comprises an elaborate executive summary, including a market snapshot that provides overall information of various segments and sub-segments.

Drugs by Therapeutic Area
Human Growth Hormone Market (Route of Administration- Intravenous, Subcutaneous, Intramuscular, Oral; Distribution Channel– Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Clinics; Indication- Growth Hormone Deficiency, Turner Syndrome, Idiopathic Short Stature, Prader-Willi Syndrome, Other Indications) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 - 2026 Featured

Jan, 2018 | 170 pages

A lot of research activities are being conducted on growth hormone and how it can be used to reverse various health problems. Among various biological effects, injecting growth hormone has been found to decrease body fat and increase muscle mass. 

Drugs by Therapeutic Area
Dry Eye Disease Market (Product - Artificial Tears, Anti-inflammatory (Cyclosporine, Corticosteroid, and Lifitegrast), Punctal Plugs, and Secretagogue; Distribution Channel - Hospital Pharmacies, Independent Pharmacies & Drug Stores, and Online pharmacies) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2017 - 2025

Jan, 2018 | 201 pages

Dry eye is an ocular disease caused due to insufficiency or lack of tears in eye. Tears made up of three layers viz. lipids, mucin and aqueous keep eye moist and lubricated. Lack of tears lead to redness, burning, sensing and pain in eye. Dry eye disease also known as Keratoconjuctivitis Sicca is a common phenomenon, which is estimated to have prevalence of 8% to 34% across the globe.

Drugs by Therapeutic Area
Thrombin Market (Product - Bovine Thrombin, Human Thrombin, and Recombinant Thrombin; Dosage Form - Powder Form and Solution Form; End User - Hospitals, Diagnostics Centers & Clinics, and Academics & Research Institutes) - Global Industry Analysis, Size, Share, Growth, Trends, & Forecast 2017 - 2025

Jan, 2018 | 162 pages

This report on thrombin market studies the current as well as future prospects of the market globally. The stakeholders of this report include companies and intermediaries engaged in the manufacturing and commercialization of thrombin products as well as new entrants planning to enter this market.

Drugs by Therapeutic Area
Influenza Medication Market (Product - Zanamivir, Oseltamivir, Peramivir, Amantadine, Rimantadine, Inosine, and Laninamivir Octanoate; Distribution Channel - Hospitals, Clinics, and Pharmacies) - Global Industry Analysis, Size, Share, Growth, Trends, & Forecast 2017 - 2025

Jan, 2018 | 159 pages

This report on Influenza Medication Market studies the current as well as future prospects of the market globally. The stakeholders of this report include companies and intermediaries engaged in the manufacture, commercialization, providing services of Influenza Medication Market products such as Zanamivir, Oseltamivir, Peramivir, and others as well as new entrants planning to enter this market.

Drugs by Therapeutic Area
Antibacterial Drugs Market (Drug Class - B - lactams, Quinolones, Macrolides, Tetracycline, Aminoglycoside, Sulfonamide, and Phenicols; Routes of Administration - Enteral and Parenteral; Distribution Channel - Hospital Pharmacies, Drug Stores and Retail Pharmacies, and Online Sales) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025

Dec, 2017 | 189 pages

This report provides in-depth region wise and country wise analysis of the antibacterial drugs market. Stakeholders of this report include manufacturers of antibacterial drugs, raw material suppliers, researchers and new players planning to enter the market.

Drugs by Therapeutic Area
Diabetes Drugs Market (Therapy - Glucagon-like Peptide-1 (GLP-1) Agonist, Dipeptidyl-peptidase-4 (DPP-4) Inhibitors, Sodium Glucose Co-transporter 2 (SGLT2) Inhibitors, and Insulin; Disease Type - Type 1 Diabetes, Type 2 Diabetes, Gestational Diabetes, Impaired Glucose Tolerance and Impaired Fasting Glycaemia; By Distribution Channel - Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025

Dec, 2017 | 223 pages

This report on the Diabetes drugs market analyzes the current and future scenario of the global market. Rise in private and public funding for diabetes drugs, rising prevalence of diabetes, and favorable regulatory scenario for new drug launch are boosting the growth of the Diabetes drugs market. Increasing geriatric population across the world and rising incidence and prevalence of diabetes such as Type 2 diabetes and Type 1 diabetes are some of the factors expected to drive the growth of Diabetes drugs market during the forecast period.

Drugs by Therapeutic Area
Poultry Health Market (Treatment - Therapeutics (Vaccines Feed Additives, Anti-Infectives, and Paraciticides, Diagnostic (Test, ELISA, and PCR) Imaging, and Genetics) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2017 - 2025

Dec, 2017 | 175 pages

This report on poultry health market studies the current as well as future prospects of the market globally. The stakeholders of this report include companies and intermediaries engaged in the manufacture, commercialization, providing products of poultry health as well as new entrants planning to enter this market. 

Drugs by Therapeutic Area
Carglumic Acid Market (Delivery Format- Tablet, orally disintegrating, Tablet, for suspension; Distribution Channel- Hospital Pharmacies, Retail Pharmacies, E-Commerce) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 - 2026 Featured

Dec, 2017 | 170 pages

Transparency Market Research (TMR) has compiled a new comprehensive report on the global carglumic acid market for the forecast period 2017 to 2026. The report offers insightful forecasts on global carglumic acid market, and has examined the market in detail, providing key market dynamics inclusively. In addition to the provision of intelligence on latest trends, restraining factors, and fostering factors affecting the market expansion, the report includes analysis on data pertaining to multiple market parameters.

Drugs by Therapeutic Area
Anti-Venom Market - (Anti-Venom Type - Monovalent and Polyvalent; Product Type - Snake Anti-Venom, Scorpion Anti-Venom, and Spider Anti-Venom; Distribution Channel - (Hospitals, Clinics and Ambulatory Surgical Centers) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025

Dec, 2017 | 192 pages

This report on anti-venom market studies the current as well as future prospects of the market globally. The stakeholders of this report include companies and intermediaries engaged in the manufacture and commercialization of anti-venom products as well as new entrants planning to enter this market. This report comprises an elaborate executive summary along with a market snapshot providing overall information of various segments and sub-segments considered within the scope of the study. 

Drugs by Therapeutic Area
Myasthenia Gravis Market (Treatment- Drug Treatment (Cholinesterase Inhibitors, Monoclonal Antibodies, and Chronic Immunomodulators) and Rapid Immunotherapies (Plasmapheresis, Intravenous Immunoglobulin (IVlg), and Thymectomy)) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025

Dec, 2017 | 161 pages

Myasthenia gravis is a chronic, debilitating and neuromuscular autoimmune disease that can take place at any time of life but most often starts for men after the age of 55 and women around the age of 40.

Drugs by Therapeutic Area
Wound Debridement (Wound Cleaning) Market (Method - Autolytic/ Traditional Methods, Enzymatic Method, Mechanical Method, Surgical Method, and Maggot/Biotherapy Method; Type of wound - Chronic Wounds, Acute Wounds, and Burns) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 - 2025

Nov, 2017 | 217 pages

This report on wound debridement studies the current as well as future prospects of the market globally. The stakeholders of this report include companies and intermediaries engaged in the manufacture and commercialization of various products as well as new entrants planning to enter this market. 

Drugs by Therapeutic Area
Anti-Obesity Prescription Drugs Market (By Drug Class - Bupropion and Naltrexone, Orlistat, Lorcaserin, Phentermine and Topiramate, Liraglutide; Age Group - Pediatric, Adult; Distribution Channel - Hospitals Pharmacies, Retail Pharmacies, E-commerce) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 - 2026 Featured

Nov, 2017 | 170 pages

The global anti-obesity prescription drugs market is expected to witness a moderate growth attributed to growing prevalence of obesity globally. Moreover, surge in consumption of unhealthy food products that are rich in cholesterol has led to an upsurge in demand anti-obesity prescription drugs. 

Drugs by Therapeutic Area
Sexually Transmitted Diseases (STDs) Drug Market (Disease Type - Chlamydia, Gonorrhea, Syphilis, Genital herpes, HPV, and HIV / AIDS; Therapy Class- Antibiotics, Antiviral / Antiretrovirals, and Vaccines) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025

Nov, 2017 | 293 pages

Sexually transmitted diseases (STDs), also referred as venereal diseases are infections that can pass from person to person during sex. These diseases are caused mainly due to bacteria, viruses, and / or parasites. Sexually transmitted diseases (STDs) often go undiagnosed because these infections usually do not exhibit visual symptoms. 

Drugs by Therapeutic Area
Pain Management Therapeutics Market (Therapeutics - Anticonvulsants, Antidepressants, Anesthetics, Non-steroidal Anti-inflammatory Drugs (NSAIDS), Opioids, Other Non-narcotic Analgesic, and Antimigraine Agents; Indication - Neuropathic Pain, Fibromyalgia, Arthritic Pain, Chronic Back Pain, Migraine, Post-Operative Pain, and Cancer Pain) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025

Nov, 2017 | 166 pages

This report on the pain management therapeutics market studies the current as well as future prospects of the market globally. The pain management therapeutics market report comprises an elaborate executive summary along with a market snapshot providing overall information of various segments and sub-segments considered in the scope of the study. 

Drugs by Therapeutic Area
Rheumatology Therapeutics Market (Drug Class - Disease Modifying Anti-rheumatic Drugs (DMARD’s), Nonsteroidal Anti-inflammatory Drugs (NSAID’s), Corticosteroids, and Uric Acid Drugs; Disease Indication - Rheumatoid Arthritis, Osteoarthritis, Gout, Psoriatic Arthritis, and Ankylosing Spondylitis; Distribution Channel - Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy) Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017-2025

Oct, 2017 | 205 pages

Rheumatology is the discipline of internal medicine that involves the diagnosis and treatment of rheumatic diseases. Rheumatic diseases are characterized by the inflammation that affects joints, tendons, ligaments, bones and sometimes organs. Rheumatic diseases are also called as musculoskeletal disease causes severe pain, deformity and morbidity and leads to heavy economic burden due to high cost of treatment.

Drugs by Therapeutic Area
Plasma Protease C1-inhibitor Treatment Market (Drug Class- C1-inhibitors (C1-esterase Inhibitor and Recombinant Inhibitor), Kallikrein Inhibitor (Kalbitor), and Selective Bradykinin B2 Receptor Antagonist (Firazyr); Distribution Channel - Hospital Pharmacies and Independent Pharmacies and Outlets; Dosage Type - Lyophilized and Liquid/Injectable) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 - 2025

Oct, 2017 | 173 pages

This report on the plasma protease C1-inhibitors treatment market analyzes the current and future scenario of the global market. Large number of acute HAE patients is increasing the usage of plasma protease C1-inhibitors treatment. Increasing prevalence of rare diseases around the world, promising pipeline drugs and novel therapies, rising investments in innovation of inhibitor drugs and increasing HAE awareness programs are the major drivers of the global plasma protease C1-inhibitors treatment market.

Drugs by Therapeutic Area
Antacids Market (Drug Class - Proton Pump Inhibitor, H2 Antagonist, and Acid Neutralizers; Formulation Type - Tablet, Liquid, and Powder; Distribution Channel - Hospital Pharmacies and Retail Pharmacies) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025

Oct, 2017 | 184 pages

This report on the global antacids market analyzes the current and future prospects of the market. The report comprises an elaborate executive summary, including a market snapshot that provides overall information of various segments and sub-segments.

Drugs by Therapeutic Area
Migraine Drugs Market (Treatment - Abortive (Triptans and Ergot Alkoids) and Prophylactic (Botulinum Toxin and Topiramate); Route of Administration - Oral and Injectable; Distribution Channel - Retail Pharmacies and Hospital Pharmacies) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025

Oct, 2017 | 214 pages

This report on the global migraine drugs market analyzes the current and future prospects of the market. The report comprises an elaborate executive summary, including a market snapshot that provides overall information of various segments and sub-segments.

Drugs by Therapeutic Area
Orphan Drugs Market (Disease Type - Oncology, Gastrointestinal, Pulmonary, Neurology, Hematology, Cardiovascular, Metabolic disorders, Endocrinology, and Infectious diseases; Product Type - Biologic and Non-biologic; Distribution Channel - Hospital Pharmacies, Specialty Pharmacies, Retail Pharmacies, and others) - Global Industry Analysis, Size, Share, Volume, Growth, Trends, and Forecast 2017 - 2025

Sep, 2017 | 199 pages

The underlying reasons that are fuelling demand for orphan drugs are the increasing occurrences of rare diseases. During forecast timeframe of 2017 to 2025, the world market for orphan drugs is prognosticated to register a robust rate of growth, and the same is supported by several factors like sound research and development for orphan drugs especially in the developed economies, growing incidences of rare diseases, and high return on investments (ROI) that can be obtained for the invention and development of these drugs.

Drugs by Therapeutic Area
Subcutaneous Immunoglobulin Market (Application - Primary Immunodeficiency Diseases and Secondary Immunodeficiency Diseases; End User - Hospitals, Clinics, and Home Care) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

Aug, 2017 | 145 pages

Primary humoral immunodeficiency or primary immune deficiency diseases (PIDD) is a group of disorders in which the immune system of an individual does not function properly. In PIDD patients, the number of antibodies produced in the body is not sufficient, or the ones produced are defective. PIDDs are thus often characterized by increased vulnerability to infections. According to the International Union of Immunological Societies (IUIS), PIDD is a compilation of more than 150 different diseases.

Drugs by Therapeutic Area
Hereditary Angioedema Market (Drug Class - C1 Esterase Inhibitor (Cinryze, Berinert, and Ruconest), Selective Bradykinin B2 Receptor Antagonist (Firazyr), and Kallikrein Inhibitor (Kalbitor); Route of Administration - Intravenous, Subcutaneous Injection, and Oral; Distribution Channel - Hospital Pharmacies and Retail Pharmacies) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025

Aug, 2017 | 153 pages

This report on the global hereditary angioedema market analyzes the current and future prospects of the market. The report comprises an elaborate executive summary, including a market snapshot that provides overall information of various segments and sub-segments.

Drugs by Therapeutic Area
Alzheimer’s Drugs Market (Drug class - Cholinergic, Memantine, and Combined Drug; Distribution Channel - Hospital Pharmacy, Retail Pharmacy, and Online Sales) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025

Aug, 2017 | 175 pages

This report on the Alzheimer’s drugs market analyzes the current and future scenario of the global market. Increasing prevalence of Alzheimer’s, innovation in the development of new drugs, biomarker analysis and most promising molecules analysis, drug class sales during the forecast period.

Drugs by Therapeutic Area
Alpha 1 Antitrypsin Deficiency Treatment Market (Treatment Type - Augmentation Therapy, Bronchodilators, Corticosteroids, and Oxygen Therapy; End-user - Hospitals, Specialty Clinics, and Pharmacies; Route of Administration - Parenteral, Inhalation, and Oral) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025

Aug, 2017 | 153 pages

Alpha-1 Antitrypsin also referred as AAT, is a type of protein belongs to the class protease inhibitor. This protein is produced in the liver and is primarily functions to protect the lungs and liver from the harmful effects of other protein in the body. The AAT deficiency is genetic disorder that causes low and defective production of AAT proteins in liver which results in the accumulation of AAT in the liver and low amount of it in blood stream.

Drugs by Therapeutic Area
Diabetic Neuropathy Market (Disorder Type - Peripheral Neuropathy, Autonomic Neuropathy, Proximal Neuropathy, and Focal Neuropathy; Treatment Type - Drugs (Analgesic (Topical, Opioid, and NSAIDs), Antidepressants (TCAs, SNRIs, and SSRIs), and Anticonvulsant Drugs (Gabapentin, Pregabalin, and Topiramate), Radiotherapy (Transcutaneous Electrical Nerve Stimulation (TENS)), and Physiotherapy; Distribution Channel - Hospitals, Clinics, Retail Pharmacy, and Online Pharmacy) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025

Jun, 2017 | 251 pages

The report on diabetic neuropathy market analyzes the current and future scenario of the global market. Increase in prevalence of diabetic neuropathy, advent of new therapeutics for treatment of neuropathy, favorable reimbursement scenario, and investment from key players in development of cost effective therapeutics for diabetic neuropathy are the major drivers of the global diabetic neuropathy market.

Drugs by Therapeutic Area
Chlamydia Infection Diagnostics and Therapeutics Market (Product Type - Diagnostics (Nucleic Acid Amplification Tests (NAATs) and Direct Fluorescent Tests) and Therapeutics (Macrolides, Quinolones, Sulfonamides, Tetracycline, and Aminopenicillins); End Users - Hospitals, Specialty Clinics, Diagnostic Centers Therapeutics, Hospital Pharmacies, Drugstores, Retail Pharmacies, and Online Pharmacies) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025

Jun, 2017 | 211 pages

Chlamydial infection, caused by Chlamydia trachomatis, is the most common contagious sexually transmitted infection and results in significant economic cost and morbidity worldwide. Occurs most commonly in young sexually active population, C. trachomatis causes urethritis in men and cervicitis in women, as well as extra-genital infections, including pharyngeal and rectal infections. Asymptomatic infections are common in both men and women. 

Drugs by Therapeutic Area
Animal Health Care Market (Zone - North India, East India, West India, South India; Animal Type Livestock (Bovine, Porcine, Ovine, and Poultry) and Companion (Canine and Feline); Distribution Channel - Veterinary Hospitals, Veterinary Clinics, Pharmacies, Drug Stores, Direct Distribution, and Pet Shops) - India Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

Apr, 2017 | 378 pages

In terms of revenue, the India animal health care market is expected to register a CAGR of 8.0% during the forecast period, 2016–2024. The primary objective of the report is to offer insights on the market dynamics that can influence  growth  of the India animal health care market over the forecast period. Insights on key trends, drivers, restraints, value forecasts and opportunities for companies operating in the India animal health care market are presented in the report.

Drugs by Therapeutic Area
Pharmerging Market (Product Type - Pharmaceuticals (Branded Prescription Drugs, Generic Drugs (Branded Generics, Unbranded Generics, and OTC Drugs) and Healthcare (Medical Devices, Diagnostic Instruments, and IT and Record Management); Economic Growth Levels - Tier - 1, Tier - 2, and Tier - 3; Indications - Lifestyle Diseases, Cancer and Autoimmune Diseases, and Infectious Diseases; Distribution Channel - Hospitals, Clinics, Retail Pharmacies, E-commerce, and Drug Stores) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025

Apr, 2017 | 192 pages

This report on  pharmerging  market studies the current as well as future prospects of the market globally. The stakeholders of this report include companies and intermediaries engaged in the manufacture and commercialization of various pharmaceutical products as well as new entrants planning to enter this market. This report comprises an elaborate executive summary along with a market snapshot providing overall information of various segments and sub-segments considered within the scope of the study. 

Drugs by Therapeutic Area
Transdermal Scopolamine Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

Apr, 2017 | 103 pages

Scopolamine is an alkaloid, a secondary metabolite produced by plants of nightshade family such as henbane, Datura, Duboisia, etc. Scopolamine is used to treat motion sickness, and post-operative and  anesthesia induced  nausea and vomiting. It is often used to treat gastrointestinal spasm, irritable bowel  syndrome  and eye inflammation. Scopolamine is also used for nausea and vomiting prevention in chemotherapy for cancer treatment. Scopolamine can be administered orally as tablets or syrups, intravenously as injections and solutions, or as transdermal in form of patch or gel.

Drugs by Therapeutic Area
Substance Abuse Treatment Market (Abuse Type - Alcohol Dependence, Tobacco/Nicotine Addiction, and Opioid Addiction; Treatment Type - Alcohol Addiction Treatment (Disulfiram, Acamprosate, and Naltrexone), Tobacco/Nicotine Addiction Treatment (Nicotine Replacement Treatment and Non-nicotine Medication), Drug Abuse Treatment (Methadone, Buprenorphine, and Naltrexone); End User - Outpatient Treatment Centers, Residential Treatment Centers, and Inpatient Treatment Centers) - U.S. Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

Mar, 2017 | 74 pages

This report on substance abuse treatment, studies the current as well as future prospects of the market across the U.S. Substance abuse refers to the harmful or hazardous use of psychoactive substances, including illicit drugs and alcohol. Excessive use of  psychoactive substance can lead to dependence syndrome, that include a strong desire to take drug, difficulties in controlling its use, increased tolerance and sometimes a physical withdrawal state. 

Drugs by Therapeutic Area
Animal Blood Plasma Products and Derivatives Market (Derivatives Type - Immunoglobulin, Fibrinogen, Serum Albumin, and Fetal Bovine Serum; Application - Cell Culture Media, Food Industry, Pharmaceutical Industry, Sports Nutrition, Nutrition Supplements, Cosmetic Industry, Diagnostic Industry, and Pet Food Industry; Animal Type - Bovine and Ovine) - Global Industry Analysis, Size, Share, Growth, Trends, & Forecast 2016 - 2024

Mar, 2017 | 223 pages

This report on animal blood plasma products and derivatives market studies the current as well as future prospects of the market globally. The stakeholders of this report include companies and intermediaries engaged in the manufacture, commercialization, providing products and derivatives of animal blood plasma such as Immunoglobulin, Fibrinogen, Serum Albumin, Fetal Bovine Serum, and Others (thrombin, new born calf serum, etc.) as well as new entrants planning to enter this market. 

Drugs by Therapeutic Area
Chronic Kidney Disease (CKD) Drugs Market (Drug Class - ACE Inhibitors, Angiotensin-II Receptor Blockers, Calcium Channel Blockers, Beta Blockers, Erythropoiesis - stimulating Agents (ESAs), and Diuretics; End User - Hospitals and Specialty Clinics) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

Mar, 2017 | 143 pages

This report on the global chronic kidney disease (CKD) drugs market analyzes the current and future prospects of the market. The report comprises an elaborate executive summary, including a market snapshot that provides overall information of various segments and sub-segments. The research is a combination of primary and secondary research.  Primary  research formed the bulk of our research efforts along with information collected from telephonic interviews and interactions via e-mails. 

Drugs by Therapeutic Area
Veterinary Drugs Market (Product Type - Anti-infective, Anti-inflammatory, and Parasiticides; Animal - Companion and Livestock; Route of Administration - Oral, Parenteral, and Topical) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

Mar, 2017 | 155 pages

This report on the veterinary drugs market analyzes the current and future scenario of the global market. Increase in pet ownership, rise in healthcare expenditure on companion animals, rise in meat consumptions along with high demand for good quality proteins are some of the drivers expected to drive the global veterinary drugs market during the forecast period.

Drugs by Therapeutic Area
Antiviral Drugs Market (Disease Indication - Hepatitis Virus Infection, HIV Infection, and Respiratory Virus Infection; Product Type - Branded Drugs and Generic Drugs; Distribution Channels - Hospital Pharmacy Store, Retail Pharmacy Store, and Online Pharmacy) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2016 - 2024

Mar, 2017 | 184 pages

In past 30 years, significant progress is seen in antiviral drugs market, mainly in case of the drugs that target the entry and escaping mechanisms of viruses, with an aim of improving the quality of patient’s life by introducing broad spectrum of combination therapy drugs.

Drugs by Therapeutic Area
Gastrointestinal Drugs Market (Drug Class - Acid Neutralizers (Antacids, H2 Antagonists, and Proton Pump Inhibitors), Antidiarrheal and Laxatives, Antiemetic and Antinauseants, Anti-inflammatory Drugs, Biologics, and Antispasmodic; Route of Administration - Oral, Parenteral and Rectal; Disorder Type - Gastro-esophageal Reflux Disease, Inflammatory Bowel Disease, and Irritable Bowel Syndrome; Distribution Channel - Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

Mar, 2017 | 217 pages

Gastro esophageal  reflux disease (GERD), inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS) are types of gastrointestinal disease.  gastro esophageal  reflux disease (GERD) is a chronic gastric illness that arises when acidic juices in the stomach come back up into the esophagus from stomach, this can leads to irritation of esophagus and causes symptoms like heartburn, gas, etc. Inflammatory bowel disease is a group of chronic inflammation of small and large intestine. 

Drugs by Therapeutic Area
Cryptococcosis Market (Treatment - Amphotericin B (Amphocin and Fungizone), Flucytosine (Ancobon), Fluconazole (Diflucan), Voriconazole and Surgery Treatment; Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Drug Store, and Mail Order Pharmacies) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

Feb, 2017 | 166 pages

This report on the global cryptococcosis market analyzes the current and future scenario of the global market. Cryptococcosis disease burden is rising due to increase in susceptible patient population such as HIV-infected patients, solid organ transplantation recipients, and other immunosuppressive hosts. In addition, the huge patient base in Sub-Saharan countries fuels the growth of the cryptococcosis market. For instance, According to CDC, it is estimated that around 1 million cryptococcal meningitis cases occurs globally. 

Drugs by Therapeutic Area
Short Bowel Syndrome Market (Drug Class - GLP-2, Growth Hormone, and Glutamine) - Global Industry Analysis, Size, Share, Volume, Growth, Trends, and Forecast 2016 - 2024

Jan, 2017 | 124 pages

Short bowel syndrome (SBS) is an intestinal disorder associated with malabsorption due to the lack of functional intestine. SBS can be congenital or an acquired condition which can be observed in patients in whom nearly half of the small intestine has been removed due to underlying disease condition. In certain instances, a major part of the large intestine is removed through surgeries that might result in SBS in the patients. The major causes of SBS in infants include necrotizing enterocolitis, intestinal atresia, gastroschisis, and malrotation with volvulus, among others.

Drugs by Therapeutic Area
Non-alcoholic Steatohepatitis (NASH) Biomarkers Market (Marker Type - Serum Biomarkers, Hepatic Fibrosis Biomarkers, Apoptosis Biomarkers, and Oxidative Stress Biomarkers; End User - Contract Research Organizations (CRO) and Pharmaceutical Industry, Academic Research Institute, Hospitals, and Diagnostic Laboratories) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

Jan, 2017 | 152 pages

Non-alcoholic steatohepatitis (NASH) is liver disease which is categorized under the spectrum of non-alcoholic fatty liver disease (NAFLD). NASH is an advanced form of NAFLD where the liver inflammation occurs owing to fat deposition in liver. The fat accumulation may be induced by genetic abnormalities, metabolic dysfunction, drug induced damages, etc. Untreated and advanced NASH is one of the major reason for liver cirrhosis and sever liver damage such as liver failure.

Drugs by Therapeutic Area
Facial Injectables Market (Product - Botulinum Toxin, Hyaluronic Acid, Collagen, (Porcine/Bovine-based and Human-based), Particle & Polymer Fillers (PPF) (Polymethylmethacrylate Beads (PMMA microspheres), Poly-L-Lactic Acid, and Calcium Hydroxyapatite; Treatment - Facial Pain, Wrinkle Treatment, and Lip Augmentation; End User - Hospitals, Ambulatory Surgical Centers, Cosmetic Centers, Dermatology Clinics, and Physician Clinics) - North America Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

Jan, 2017 | 93 pages

This report on the North America facial injectables market analyzes the current and future prospects of the market. The report comprises an elaborate executive summary, including a market snapshot that provides overall information of various segments and sub-segments. A detailed qualitative analysis of factors responsible for driving and restraining market growth and future opportunities has been provided in the market overview section. 

Drugs by Therapeutic Area
Psoriasis Treatment Market (Product - TNF Inhibitors, Vitamin D Analogues or Combinations, and Interleukin Blockers; Therapy - Topical Therapeutic Drugs, Systemic Therapeutic Drugs, and Combinations; Distribution Channel - Hospital Pharmacy, Retail Pharmacy, and Online Sales) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

Jan, 2017 | 178 pages

This report on the Psoriasis Treatment market analyzes the current and future scenario of the global market. Approval of new biologics, increase in access for the treatment in developing market, increase in the number of psoriasis patients, are boosting the growth of the global Psoriasis Treatment market. 

Drugs by Therapeutic Area
Alpha Mannosidosis Market (Treatment - Bone Marrow Transplant (BMT) and Enzyme Replacement Therapy (ERT); Indication - Type I, Type II and Type III; End Users - Hospitals and Specialty Clinics) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2024

Jan, 2017 | 109 pages

With increase in the incidence of alpha mannosidosis worldwide the market for treatment is expected to grow in coming years. Alpha Mannosidosis is a rare inherited condition that leads to problems in organs and tissues of the body. The disease is of three types such as Type I, Type II and Type III.  Type I is a mild form, type II is moderate form of disease and most commonly observed, whereas, type III is the severe form of disease. 

Drugs by Therapeutic Area
Neurological Disorder Drugs Market (Disorder - Epilepsy, Parkinson’s Disease, Alzheimer’s Disease, Multiple Sclerosis, and Cerebrovascular Disease; Drug Type - Anticholinergic, Antiepileptic, Antipsychotic, Analgesics, Hypnotic & Sedative, Antihypertensive, and Anticoagulants; Distribution Channel - Hospital Pharmacy, Retail Pharmacy, and eCommerce) - Europe Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

Dec, 2016 | 224 pages

This research report provides a detailed analysis of the neurological disorder drugs market and helps understand the various driving factors for the growth of the market. The market overview section analyzes market dynamics and trends such as drivers, restraints and opportunities that influence the current nature and future status of the market. Market dynamics factors such as market attractiveness analysis have also been explained in order to deliver a thorough analysis of the overall competitive scenario of the Europe neurological disorder drugs market.

Drugs by Therapeutic Area
Hospital Acquired Infection Treatment Market (Infection Type - Urinary Tract Infections, Ventilator Associated Pneumonia, Bloodstream Infections, Surgical Site Infections, Gastrointestinal Infection, ENT Infections, Skin Infection, and Bone Infection; Treatment Type - Antibacterial, Antiviral, Antifungal Treatment, Antiparasitic, Antiprotozoal, and Anti-TB Treatment; Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Drug Store, and E-Commerce) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

Dec, 2016 | 198 pages

This report on hospital acquired infection treatment, studies the current as well as future prospects of the market globally. Hospital infections are also referred to as healthcare-associated infections (HAIs), or nosocomial infections or hospital-acquired infection (HAIs). HAIs can be defined as those infections that occur in patients when they are admitted to a hospital or any other health-care facility with which they were not suffering from at the time of their admission.

Drugs by Therapeutic Area
Porcine Vaccine Market (Disease Indication - Diarrhea, Swine Influenza, Arthritis, Bordatella Rhinitis, Porcine Reproductive and Respiratory Virus (PRRSV), and Porcine Circovirus Associated Disease (PCVAD); End User - Veterinary Hospitals and Hog/Pig Production Farms; Technology - Inactivated Vaccines, Live Attenuated Vaccines, Toxoid Vaccines, Recombinant Vaccines, Conjugate Vaccines, and DNA Vaccines) - North America Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

Nov, 2016 | 131 pages

This report on the porcine vaccine market analyzes the current and future scenario of the North America market. Increase in disease indication among swine, technological advancement of RNA strand methodology, and cultivation of pig for growth in standard of living is accounted to form growth in porcine vaccine segment.   Increase trading facilities of live hogs/pigs, demand of pork meat and innovation through clinical research activities are some of the drivers expected to drive the North America porcine vaccine market during the forecast period. 

Drugs by Therapeutic Area
Hematological Malignancies Market (Disease Condition - Leukemia, Lymphoma, and Myeloma; Therapy - Chemotherapy, Immunotherapy, and Targeted Therapy; Distribution Channel - Hospital Pharmacies, Medical Stores, and E-commerce Platform) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

Nov, 2016 | 152 pages

This report provides in-depth region wise and country wise analysis of the hematological malignancies market. Stakeholders of this report include manufacturers of hematology cancer drugs, raw material suppliers, cancer drug processing companies, and new players planning to enter the market. It further presents qualitative and quantitative analysis of the global hematological malignancies market. 

Drugs by Therapeutic Area
Uterine Fibroids Treatment Market (Procedure Type - Endometrial Ablation, MRI Guided Procedures (Percutaneous Laser Ablation and Transcutaneous Focused Ultrasound), Hysterectomy (Abdominal, Vaginal, Laparoscopic, Robotic, and Hysteroscopic Morcellation), Myomectomy (Open, Laparoscopic, and Robotic), Uterine Artery Embolization, and Radiofrequency Ablation; End User - Hospitals and Ambulatory Surgical Centers - U.S. Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

Nov, 2016 | 102 pages

The uterine fibroid treatment market is driven by growing number of hysterectomy surgeries every year in the country. Furthermore, the rising coverage of healthcare and increasing prevalence of non-cancerous tumors in women of childbearing age is expected to be the most vital reason for expansion of the uterine fibroids market growth.

Drugs by Therapeutic Area
Pulmonary Drugs Market (Drug Class - Inhaled Corticosteroids (ICS), Long-Acting Beta2-Agonists (LABA), Antihistamines, Vasodilators, Short-Acting Beta2-Agonists (SABA), Anticholinergics, Combination Drugs, MAbs, Enzymes, Antibiotics, and Antileukotrienes; Application - Asthma & COPD, Allergic Rhinitis, Pulmonary Arterial Hypertension, and Cystic Fibrosis; Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Drug Stores, and E-commerce) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 – 2024

Nov, 2016 | 196 pages

This report on pulmonary drugs studies the current as well as future prospects of the market globally. The stakeholders of this report include companies and intermediaries engaged in the manufacture and commercialization of various pulmonary/respiratory drugs and/or drug-device combinations as well as new entrants planning to enter this market. 

Drugs by Therapeutic Area
Clostridium Vaccine (Animal Health) Market (Animal Species - Bovine, Ovine, Caprine, Swine, and Poultry; Distribution Channel - Veterinary Clinic, Veterinary Hospital, Veterinary Research Institute, and Retail Pharmacy) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2016 - 2024

Nov, 2016 | 161 pages

This report on the clostridium vaccine (animal health) market studies the current as well as future prospects of the market globally. Health concern related to life threatening diseases are the major concerns in the developed and developing nations.

Drugs by Therapeutic Area
Homeopathy Product Market (Product Type - Tincture, Dilutions, Biochemics, Ointments, and Tablets; Application - Analgesic and Antipyretic, Respiratory, Neurology, Immunology, Gastroenterology, and Dermatology; Source - Plants, Animals, and Minerals) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

Nov, 2016 | 219 pages

This report by Transparency Market Research on the global homeopathy product market for the period 2016–2024 presents an outlook of the market across the globe. The primary objective of the report is to offer updates on market opportunities in the global homeopathy product market.  

Drugs by Therapeutic Area
Bovine Respiratory Disease Treatment Market (Treatment Type - Vaccines, Antibiotics, NSAIDs, and Immunomodulators; Disease Type - Upper Respiratory Tract Infections, Pneumonia (Lower Respiratory Tract Infection), and Diphtheria; Distribution Channel - Veterinary Hospitals, Veterinary Clinics, Private Veterinary Pharmacies, and Veterinary Research Institutes) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

Oct, 2016 | 165 pages

Bovine respiratory disease (BRD) is a multifactorial and complex disorder caused due to combination of more than one microbial pathogens, impaired host immunity, inadequate housing conditions, and environmental factors. The major factor leading to bovine respiratory diseases are host factors, environmental factors, and direct influence of infectious agents such as virus, bacteria, and parasites. 

Drugs by Therapeutic Area
Allergy Diagnostics Market (Product - Assay Kits, Consumables, and Instruments; Allergen Type - Inhaled Allergens, Food Allergens, and Drug Allergens; Test Type - In-vivo and In-vitro tests; End Users - Hospitals, Diagnostic Laboratories, and Academic Research Institutes) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

Oct, 2016 | 197 pages

Allergy diagnostics includes products and tests that are used to determine the presence of allergens such as grass, weed, peanuts, milk, or drugs etc. in the samples by determining the presence of antibodies developed by the immune system. The report on global allergy diagnostics market, analyzes the current and future prospects of the market. 

Drugs by Therapeutic Area
Asthma and COPD Drugs Market (Drug Class - Bronchodilators, Anti-inflammatory Drugs, Monoclonal Antibodies, and Combination Drugs; Indication - Asthma and COPD) - U.S. and China Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

Oct, 2016 | 101 pages

Asthma is a disease characterized by recurrent attacks of coughing, chest-tightening, breathlessness, and wheezing as the airways narrow and swell that vary in severity and frequency. COPD is a disease of the lungs characterized by obstruction to airflow that interferes with normal breathing. According to the WHO, COPD accounted for over 3 million deaths in 2012, which is equal to 6% of all deaths globally in that year. 

Drugs by Therapeutic Area
Biologics Market (Product - Monoclonal Antibodies, Vaccines, Cell Therapy, Recombinant Hormones/Proteins, and Gene Therapy; Applications - Infectious Diseases, Oncology, Immunology, and Autoimmune Diseases) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

Oct, 2016 | 179 pages

This report provides forecast and analysis of the global biologics market on the global and regional levels. It provides historical data of 2015 along with forecast from 2016 to 2024 in terms of revenue (US$ Mn). The report also includes macroeconomic indicators along with an outlook for biologics revenue annually. It includes drivers and restraints of the global biologics market and their impact on each region during the forecast period. 

Drugs by Therapeutic Area
Pharmaceutical Products and CMO Market: (Product Type - API and Ingredients, Finished Dosage Form, and Pharmaceutical Packaging) - LATAM Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

Aug, 2016 | 156 pages

This report on the pharmaceutical products and CMO market analyzes the current and future market scenario in Latin America. Most pharmaceutical companies are gradually outsourcing manufacturing activities to contract manufacturers in order to achieve efficiencies in cost, quality, capacity, and time to market or to obtain specific expertise in particular business category, which is not available in-house. 

Drugs by Therapeutic Area
Heparin Market (Product - Low Molecular Weight Heparin, Unfractionated Heparin, Ultra-low Molecular Weight Heparin; End Applications - Hospitals, Blood and Stem Cell Bank ) - Europe Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

Aug, 2016 | 101 pages

This report provides in-depth country wise analysis of the heparin market in Europe. Stakeholders of this report include manufacturers of heparin products, crude heparin suppliers, heparin processing companies, and new players planning to enter the market.

Drugs by Therapeutic Area
Testosterone Replacement Therapy Market (Product - Creams/Gels, Patches, Injections, Gums/Buccal Adhesives, Implants; Active Ingredient - Testosterone, Methyl Testosterone, Testosterone Undecanoate, Testosterone Enanthate, Testosterone Cypionate) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

Jul, 2016 | 127 pages

A range of testosterone replacement therapy (TRT) products formulated from various active ingredients are available in the market these days. At present around 30% of men worldwide suffer from hypogonadism or testosterone deficiency as shown by different studies. The percentage is substantial and in the near future it is slated to spike thereby likely effecting a demand jump for TRT products. The global market for testosterone replacement therapy is highly consolidated with the top five players accounting for a lion’s share – almost 80.0% – of the market.

Drugs by Therapeutic Area
Bacterial Conjunctivitis Drugs Market (Drug Class - Fluoroquinolones (Ciprofloxacin, Ofloxacin, Levofloxacin, Moxifloxacin, Gatifloxacin, Besifloxacin), Aminoglycosides (Tobramycin, Gentamycin), Macrolides (Erythromycin, Azithromycin)) - U.S. Industry Analysis, Pipeline Assessment, Size, Share, Growth, Trends and Forecast 2012 - 2024

Jun, 2016 | 117 pages

Bacterial conjunctivitis is a commonly encountered eye problem across the world, caused by various bacterial strains such as streptococci, staphylococci, chlamydial, and gonococci organisms. Majority of the cases of bacterial conjunctivitis are self-limited and acute and not a major cause of morbidity.

Drugs by Therapeutic Area
Nonalcoholic Steatohepatitis Therapeutics Market (Obeticholic Acid, Aramchol, Saroglitazar, and Elafibranor) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2015 - 2025

Apr, 2016 | 65 pages

Nonalcoholic fatty liver disease (NAFLD) is a disorder categorized by excess fat in the liver of people who drink little to no alcohol. No direct cause has yet been identified, however obesity and insulin resistance are believed to have major roles. Most often, NAFLD goes relatively undetected, as a liver can remain fatty without obstructing its function. 

Drugs by Therapeutic Area
Opioid Induced Constipation Treatment Market: (Mu-opioid Receptor Antagonist, Chloride Channel Activator, and Others; Solid, Semi-solid, and Liquid): Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2015 - 2023

Apr, 2016 | 91 pages

This report on the opioid induced constipation treatment market studies the current and future scenario of the global market. Large number of chronic pain sufferers is responsible for rising opioid consumption. Severe chronic constipation is a major side effect of consumption of opioid and shows resistance to traditional laxatives. 

Drugs by Therapeutic Area
Inhalation and Nasal Spray Generic Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023

Jan, 2016 | 100 pages

This report on the inhalation and nasal spray generic drugs market studies the current and future prospects of the global market. Growing incidences of respiratory diseases such as asthma and COPD, increasing geriatric population, and increasing number of generic manufacturers is expected to accentuate the growth of inhalation and nasal spray generic drugs market globally. 

Drugs by Therapeutic Area
LATAM Adalimumab Market - Industry Analysis, Size, Share, Growth, Trends, and Forecast 2015 - 2023

Jan, 2016 | 61 pages

This report on LATAM Adalimumab market analyzes the current and future prospects of the adalimumab sales pertaining to Latin American countries. The stakeholders of this report include companies engaged in production and commercialization of adalimumab biosimilars across the globe. 

Drugs by Therapeutic Area
Oral Contraceptive Pills Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023

Dec, 2015 | 71 pages

Oral contraceptive pills are birth control pills including progestin and estrogen hormones. These hormones induce contraception/birth control by preventing ovulation. These pills are also known as combined pills or combined oral contraceptive pills (COCP). Combined oral contraceptive pills are available in five different packs: the 21-day pack, the 24-day pack, the 28-day pack, the 91-day pack and the four-phase regimen.

Drugs by Therapeutic Area
Primary Immunodeficiency Diseases Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2015 - 2023

Nov, 2015 | 117 pages

This report on the primary immunodeficiency diseases (PIDD) market studies the current as well as future prospects of the market. The stakeholders of this report include pharmaceuticals companies, diagnostic kits providers, distributors, care providers and insurance companies (payers) and other intermediaries engaged in PIDD as well as new entrants that are planning to enter in this segment.

Drugs by Therapeutic Area
Hypertrophic Cardiomyopathy (HCM) Therapeutics Market - Global Industry Analysis, Pipeline Analysis, Size, Share, Growth, Trends, and Forecast 2015 - 2023

Nov, 2015 | 78 pages

This report on the hypertrophic cardiomyopathy therapeutics market studies the current and future prospects of the global market. Hypertrophic cardiomyopathy occurs if heart muscle cells enlarge and cause the walls of the ventricles (usually the left ventricle) to thicken. However, the thickening may block blood flow out of the ventricle and the condition is called obstructive hypertrophic cardiomyopathy.  

Drugs by Therapeutic Area
Spinal Muscular Atrophy Market - Pipeline Assessment, Size, Growth, Trends, and Forecast 2015 - 2023

Oct, 2015 | 44 pages

Pipeline analysis of spinal muscular atrophy (SMA) market report provides with comprehensive analysis of drugs in clinical trials for treatment for spinal muscular atrophy. The report provides insights to SMA prevalence, and current treatment pattern.

Drugs by Therapeutic Area
Organ Transplant Immunosuppressant Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023

Sep, 2015 | 102 pages

This report on the organ transplant immunosuppressant drugs market studies the current and future prospects of the global market. Organ transplant immunosuppressant drugs market are prescribed to patients during or after transplant of organs such as kidney, liver, heart, lung and bone marrow.

Drugs by Therapeutic Area
Dyslipidemia Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023

Aug, 2015 | 101 pages

With a sudden rise in the expiration of blockbuster drugs, the global market for dyslipidemia is expected to take a deep plunge in the near future. The subsequent launch of a large number of generic drugs, available at a much cheaper rate than their branded counterparts is likely to worsen the matter further. 

Drugs by Therapeutic Area
Sterilizers and Surgical, Dental Care and Equipment Disinfectors Market (By Chemical Formulations, By Applications, By End-users & By Surgery Stages) – India Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 – 2020

May, 2015 | 155 pages

Sterilizers, antiseptics, and chemical disinfectors are antimicrobial agents that are specifically used and applied in surgical and dental equipment as well as in living tissues to destroy or kill microorganisms that could infect and cross-contaminate the surgical site in patients.

Drugs by Therapeutic Area
Meningococcal Vaccines Market (Polysaccharide, Conjugate, Combination and Men B Vaccines, along with Pipeline Analysis) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2022

May, 2015 | 117 pages

Meningococcal disease, especially meningococcal meningitis, is one of the most catastrophic infections among individuals or communities. Several meningococcal serogroups have been identified till date, of which serogroups A, B, C, Y, and W-135 are the most prominent ones causing the infection. Meningococcal disease is a life threatening condition and potentially fatal illness caused due to the bacterium Neisseria meningitidis. It causes serious infection of the thin layers of connective tissue surrounding the brain and spinal cord called the meninges. 

Drugs by Therapeutic Area
Pulmonary Arterial Hypertension (PAH) Market (Prostacyclin and Prostacyclin Analogs, ERAs, PDE-5 Inhibitors, sGC Stimulators and Selexipag) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020

Apr, 2015 | 73 pages

Pulmonary arterial hypertension (PAH) is a progressive disorder, characterized by high blood pressure in pulmonary arteries that carry blood from the heart to the lungs. PAH is a very rare condition that occurs when pulmonary arteries become narrow in diameter or get blocked.

Drugs by Therapeutic Area
Dilated Cardiomyopathy Therapeutics Market [Drug Class: Aldosterone Antagonists, Angiotensin-Converting Enzyme (ACE) Inhibitors, Angiotensin II Receptor Blockers (ARBs) and Beta-Blockers] - Global Industry Analysis, Pipeline Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020

Mar, 2015 | 90 pages

Dilated cardiomyopathy is an important cause of heart failure and is one of the leading indications for heart transplantation across the globe. According to American Society for Clinical Investigation about 25% - 50% of the total dilated cardiomyopathy cases are genetically caused, owing to mutation in genes encoding for cytoskeleton, contractile, or other proteins in myocardial cells.

Drugs by Therapeutic Area
Kidney Cancer Drugs Market (Major Drugs: Afinitor (Everolimus), Avastin (Bevacizumab), Inlyta (Axitinib), Nexavar (Sorafenib), Proleukin (Aldesleukin), Sutent (Sunitinib), Torisel (Temsirolimus), Votrient (Pazopanib)) - Global Industry Analysis, Pipeline Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020

Jan, 2015 | 82 pages

Kidneys are among the most crucial organs of the human body. Their role in regulating blood pressure and serving homeostatic functions is critical in maintaining the balance of nutrients and toxins in the body. Kidneys serve as natural blood filters, removing the water-soluble wastes and reabsorbing the essential elements from the blood. 

Drugs by Therapeutic Area
Human Papillomavirus (By Drug Class and Applications) and Cytomegalovirus (By Drug Type and Applications) Therapeutics Market - Global Industry Analysis, Pipeline Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020

Jan, 2015 | 117 pages

Human papillomavirus (HPV) and Cytomegalovirus (CMV) therapeutics market report studies current as well as future prospects of the market on a global scale. The global market for HPV therapeutics is segmented by drug class and applications. Various drug classes applied against HPV infections are immunomodulators, keratolytic agents, anti-neoplastic agents, and sinecatechins. 

Drugs by Therapeutic Area
Mouth Ulcers Treatment Market (By Formulation - Mouthwash, Gel, Spray, Lozenge; By Indication - Aphthous Stomatitis, Oral Lichen Planus, Others; By Drug Class - Corticosteroid, Anesthetic, Analgesic, Antihistamine, Antimicrobial) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020

Nov, 2014 | 72 pages

Mouth ulcers, also known as aphthous ulcers, are painful open sores or lesions that are mostly found inside the mouth, either singly or in clusters. Mouth ulcers are extremely common and the prevalence rate is 2% to 60% among the global population.

Drugs by Therapeutic Area
Anxiety Disorders and Depression Treatment Market [Drug Classes: SSRIs, SNRIs, Benzodiazepines, Beta Blockers, TCAs, TeCAs, Atypical Antipsychotics, Anticonvulsants and MAOIs] - Global Industry Analysis, Pipeline Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020

Sep, 2014 | 111 pages

Anxiety disorders and depression are common psychiatric disorders that affect a large number of people during their lifetime. This study provides the market analysis for the major drug classes used for the treatment of anxiety disorders and depression. The stakeholders of this report include established pharmaceutical companies as well as new entrants who wish to enter the market.

Drugs by Therapeutic Area
Acute Ischemic Stroke Diagnosis and Treatment Market (By Diagnostics Type - CT, MRI, Ultrasound, Cerebral Angiography, Nuclear Imaging and Others By Surgery Type - Carotid Endarterectomy, Angioplasty and Endovascular Mechanical Thrombectomy) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020

Aug, 2014 | 88 pages

Acute ischemic stroke can be defined as interruption of blood supply to the brain due to the blockage of blood vessel due to atherosclerosis plaques or blood clots in the artery. Acute ischemic stroke can caused due to thrombotic or embolic occlusion of cerebral artery.

Drugs by Therapeutic Area
Osteoporosis Drugs Market (By Drug Class Bisphosphonates, Calcitonin, RANK Ligand Inhibitors, Parathyroid Hormone Therapy (PTH), Selective Estrogen Receptor Modulators (SERMs), Others Estrogen therapy and vitamin D and Calcium) - Global Industry Analysis, Pipeline Analysis, Size, Share, Growth, Trends & Forecast 2014 - 2020

Aug, 2014 | 98 pages

Osteoporosis is a chronic and life-threatening disease, in which microstructure of bones is altered due to reduction in bone mass and bone density. This condition leads to increased bone fragility and threat of bone cracks and fractures. Thus, osteoporosis is considered life threatening due to severe injury and associated pain. 

Drugs by Therapeutic Area
Biological Drugs Market (Therapeutic Protein - Levemir, Neulasta, Eylea, Rebif, NovoLog, Enbrel, Avonex, Neupogen, Humalog, Victoza, Lantus, Epogen, Aranesp, and Betaseron; Monoclonal Antibody - Avastin, Rituxan, Lucentis, Humira, Herceptin, and Remicade; Vaccine - Gardasil, Prenvar 13, Fluzone, Cervarix, and Varivax) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020

Jul, 2014 | 145 pages

The 2013 Biologics Report on pharma.org states that many biopharmaceutical research companies in America are utilizing biological processes to create 907 medicines and vaccines aimed at more than 100 diseases. At present, several biological drugs are in the pipeline for auto-immune diseases, blood diseases, cancer-related conditions, and diabetes and cardiovascular diseases.

Drugs by Therapeutic Area
Synthetic Biology Market (Synthetic DNA, Synthetic Genes, Synthetic Cells, XNA, Chassis Organisms, DNA Synthesis, Oligonucleotide Synthesis) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019

Apr, 2014 | 143 pages

Synthetic biology defined as the synthesis of artificial or natural components in order to form new artificial living system by re-molding existing biological elements. It aims to attain new preferred functions of artificially modified organisms intended for high yield production of biological systems. 

Drugs by Therapeutic Area
Rapid Medical Diagnostic Kits Market (Applications: Clinical Testing, Home-Use, Infectious Disease and Veterinary; Technologies: Lateral Flow Technology, Agglutination Assays, Flow-through and Solid-phase Assays) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

Mar, 2014 | 104 pages

The market for rapid medical diagnostic kits is expected to make impressive strides worldwide on the back of a pressing need of precautionary management of communicable conditions. Their hassle-free functionalities and the reduced turnaround time – they deliver results in under two hours – has led to their swift uptake. 

Drugs by Therapeutic Area
Organ Preservation Solutions Market (By Solutions - Viaspan, Custodiol HTK, Renograf, Hypothermosol, Perfadex, Lifor, HBS Solution, siRNA Transplant Solution and Others, and By Preservation Techniques- Hypothermic Perfusion Preservation, Static Cold Storage and Others) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

Feb, 2014 | 78 pages

Organ preservation solutions are used to preserve organs before transplantation procedure as these organs in external climate are vulnerable and also become dysfunctional once taken out from the human body. To preserve and maintain organs functionality for their further usage such as transplantation and research, organ preservation solutions are used.

Drugs by Therapeutic Area
Nanomedicine Market (Application - Neurology, Cardiovascular, Anti-inflammatory, Anti-infective, and Oncology) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019

Jan, 2014 | 81 pages

This report includes market estimations and forecast for nanomedicine products for the forecast period 2013 - 2019. The market size is represented in terms of USD billion and the market estimates and forecasts are calculated, considering 2012 as the base year. Moreover, market trends and recent developments have been kept into account while forecasting market growth and revenue for the period 2013 - 2019.

Drugs by Therapeutic Area
Implantable Drug Delivery Devices Market - Global Industry Analysis, Size, Share, Trends And Forecast 2012 - 2018

Mar, 2013 | 104 pages

The global implantable drug delivery devices market is one of the fastest growing markets in the global medical devices industry. Implantable drug delivery devices have already achieved a reasonable edge over many other drug delivery devices. The demand for implantable drug delivery devices such as implantable infusion pumps, contraceptive implants, bio-absorbable stents, intraocular drug delivery implants, and brachytherapy seeds is expected to increase in many emerging nations.

Drugs by Therapeutic Area
Liver Diseases Therapeutics Market (Chemotherapy, Anti-Virals, Vaccines, Targeted Therapy And Immunosuppressants) - Global Industry Analysis, Size, Share, Trends And Forecast 2012 - 2018

Jan, 2013 | 112 pages

The report on “Liver Diseases Therapeutics Market (Chemotherapy, Anti-Virals, Vaccines, Targeted Therapy And Immunosuppressants) - Global Industry Analysis, Size, Share, Trends And Forecast, 2012 – 2018” studies the performance of the different drugs class segments that are employed in liver disease therapeutics. These performance analyses have been performed based on revenue.

Drugs by Therapeutic Area
Asthma and COPD Drug Market - Global Industry Analysis, Market Size, Share, Trends, Growth and Forecasts 2010 - 2017

Jun, 2012 | 78 pages

The multi-billion dollar global asthma and chronic obstructive pulmonary disease (COPD) drugs market has been expanding at a steady pace, fueled primarily by the growing patient population. The World Health Organization estimates that in 2015, the number of deaths caused by COPD stood at 3 million. The organization also states that at present, there are around 235 million people suffering from asthma around the globe. While both asthma and COPD cannot be cured, the symptoms can be managed and controlled with the help of appropriate medication. 

Drugs by Therapeutic Area
China Osteoporosis Market Analysis and Forecast 2007 - 2015

Jan, 2012 | 28 pages

According to the Ministry of Civil Affairs of China, the population in China aged 60 years and above was 193.9 million at the end of 2012, accounting for 14.3% of the total population in the country. 9.4% of the total population in China was 65 years and above, which translates to 127.14 million individuals. It is no wonder then that the osteoporosis market in China has grown tremendously from 2007 to 2015.

.